Correlation Between Ocular Therapeutix and Regenxbio
Can any of the company-specific risk be diversified away by investing in both Ocular Therapeutix and Regenxbio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocular Therapeutix and Regenxbio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocular Therapeutix and Regenxbio, you can compare the effects of market volatilities on Ocular Therapeutix and Regenxbio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocular Therapeutix with a short position of Regenxbio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocular Therapeutix and Regenxbio.
Diversification Opportunities for Ocular Therapeutix and Regenxbio
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ocular and Regenxbio is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Ocular Therapeutix and Regenxbio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenxbio and Ocular Therapeutix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocular Therapeutix are associated (or correlated) with Regenxbio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenxbio has no effect on the direction of Ocular Therapeutix i.e., Ocular Therapeutix and Regenxbio go up and down completely randomly.
Pair Corralation between Ocular Therapeutix and Regenxbio
Given the investment horizon of 90 days Ocular Therapeutix is expected to generate 0.64 times more return on investment than Regenxbio. However, Ocular Therapeutix is 1.57 times less risky than Regenxbio. It trades about 0.29 of its potential returns per unit of risk. Regenxbio is currently generating about 0.07 per unit of risk. If you would invest 705.00 in Ocular Therapeutix on May 7, 2025 and sell it today you would earn a total of 530.00 from holding Ocular Therapeutix or generate 75.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ocular Therapeutix vs. Regenxbio
Performance |
Timeline |
Ocular Therapeutix |
Regenxbio |
Ocular Therapeutix and Regenxbio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ocular Therapeutix and Regenxbio
The main advantage of trading using opposite Ocular Therapeutix and Regenxbio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocular Therapeutix position performs unexpectedly, Regenxbio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenxbio will offset losses from the drop in Regenxbio's long position.Ocular Therapeutix vs. Day One Biopharmaceuticals | Ocular Therapeutix vs. X4 Pharmaceuticals | Ocular Therapeutix vs. Mereo BioPharma Group | Ocular Therapeutix vs. Terns Pharmaceuticals |
Regenxbio vs. Uniqure NV | Regenxbio vs. Rocket Pharmaceuticals | Regenxbio vs. Rhythm Pharmaceuticals | Regenxbio vs. Solid Biosciences LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Global Correlations Find global opportunities by holding instruments from different markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |